SEATTLE (AP) — Doctors say an experimental drug shows some early, encouraging signs of effectiveness in its first human test against Ebola in West Africa. But the drug helps only if patients get it soon after their symptoms first appear.
A study of the drug, favipiravir (fav-ih-PEER-ah-veer), is still in early stages in West Africa, and too few people have been treated to really know whether it helps. Other factors, like better health care, may be making a difference.
Also watch: Calvin Johnson stays alive with a jive on DWTS